Dr. Burhan Ferhanoglu Chat

• Second rank award in Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006 • Best abstract award in “4th Aegean Hematology-Oncology Symposium”, Rhodes, Greece, September 21-24, 2017 • Roche Non-Hodgkin Lymphoma” award. (Turkish Society of Hematology Roche Industry Award) in the Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006. • “TSH Clinical Laboratory Hematology” award in Turkish Society of Hematology 30th National Hematology Congress, İstanbul, 2003.

Book chapters:

• Ferhanoglu B, Ozbalak M. Diffüz Büyük B Hücreli Lenfoma (Article published in Turkish, Title: Diffuse Large B Cell Lymphoma). Ed. Teoman Soysal HematoLog-Special Issue on Lymphoma. 2013; 3(2): 355-81.
• Ferhanoglu B, Ozbalak M. Primer Merkezi Sinir Sistemi Lenfomaları (Article published in Turkish, Title: Primary Central Nervous System Lymphomas). Ed. Teoman Soysal HematoLogSpecial Issue on  Lymphoma. 2013; 3(2): 382-94.
• Burhan Ferhanoğlu, “Anemia: Definition-Classification, Hematology Course Book” University Issue Nr.: 4774, Cerrahpaşa School of Medicine Issue Nr.: 269, ISBN: 978-975- 404-815-5, page: 21-26, 2008.

Articles Published in International Journals:

• Ozyigit LP, Aktas EC, Senbas ZA, Ozturk AB, Ozturk E, Ergonul MO, Tabak L, Ferhanoglu B, Cetiner M, Deniz G. The role of atopy in the pathogenesis of bleomycin pulmonary toxicity. Respiratory medicine. 2019; 155: 1-5.
• Younes A, Brody J, Carpio C, Lopez-Guillermo A, Ben-Yehuda D, Ferhanoglu B, Nagler A, Ozcan M, Avivi I, Bosch F, Caballero Barrington MD, Hellmann A, Kuss B, Ma DDF, Demirkan F, Yagci M, Horowitz NA, Marlton P, Cordoba R, Wrobel T, Buglio D, Streit M, Hodkinson BP, Schaffer M, Alvarez J, Ceulemans R, Balasubramanian S, de Jong J, Wang SS, Fourneau N, Jurczak W. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed nonHodgkin lymphoma or chronic lymphocytic leukemia: a phase 1/2a study. The Lancet Haematology. 2019; 6(2): e67-e78
• Ferhanoglu B, Ozturk E, Ozbalak M. Venetoclax-Rituximab in Chronic Lymphocytic Leukemia. The New England journal of medicine. 2018; 378(22): 2141-2.
• Ozturk E, Akay MO, Ferhanoglu B. Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis. Turk J Haematol. 2018; 35(3): 208-9.

International Conference Presentations:

• Ferhanoğlu B, Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Özbalak M; “Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience” Poster Session in 4th Aegean Hematology-Oncology Symposium”, Rhodes, Greece, September 21-24, 2017
• Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S Catal Tatonyan S, Ongoren Aydin S, Ar MC, Baslar Z, Sayitoglu M, Ferhanoglu B, Aydin Y, Ozbek U, Soysal T Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. 53rd ASH Annual Meeting and Exposition, Oral Session, Abstract No:384, December 7-10, 2013, Louisiana, New Orleans, USA.
• Murat OZBALAK, Ilyas Tokatlı, Metin Özdemirli, Tulay Tecimer, M. Cem Ar, Serdar Örnek, Aykut Koroglu, Yahya Laleli & Burhan Ferhanoglu. 2013b. IS VALGANCICLOVIR REALLY EFFECTIVE IN PRIMARY EFFUSION LYMPHOMA?: CASE REPORT OF AN HIV(-) EBV(-) HHV8(+) PATIENT. Poster  Presentation: In 4^th International Congress of Leukemia-Lymphoma-Myeloma. Istanbul, Turkey